Citadel Advisors »

Jyong Biotech shares owned by Citadel Advisors

Quarter-by-quarter ownership of Jyong Biotech (MENS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Jyong Biotech

Tip: Access up to 7 years of quarterly data

All positions including Jyong Biotech held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jyong Biotech by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $498k 13k 39.38
2025-06-30 $591k 71k 8.33

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Jyong Biotech

Geode Capital Management
Hrt Financial
Millennium Management
Citadel Advisors
Bnp Paribas Arbitrage, Snc
UBS Group
Tower Research Capital

View all funds holding Jyong Biotech